Caprock Group’s CONMED CNMD Stock Holding History

Caprock Group’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,870	Closed	-$209K	–	370
2019 Q4	$209K	Buy	+1,870	New	+$199K	0.04%	323

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Caprock Group's CNMD Position: Q1 2020 in Review

Caprock Group sold out of CONMED (CNMD) in Q1 2020, closing a stake of 1,870 shares — an estimated $209K sold.

Caprock Group first reported a position in CNMD in Q4 2019 and held it in 1 quarter. The position peaked at $209K in Q4 2019. 229 funds tracked by Wall St. Rank hold CNMD as of Q1 2020.

Caprock Group reported no remaining CONMED position as of Q1 2020 after selling out during the quarter.
Caprock Group sold 1,870 CONMED shares in Q1 2020, an estimated $209K.
Caprock Group first reported a position in CONMED in Q4 2019 and held it in 1 quarter.
Caprock Group's CONMED position peaked at $209K in Q4 2019.
229 funds tracked by Wall St. Rank held CONMED as of Q1 2020.

Based on Caprock Group's 13F filing for Q1 2020, filed 28 Apr 2020.